Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Neisseria meningitidis C antigen assay (procedure) |
Has measured component |
False |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
|
Neisseria meningitidis C antigen assay (procedure) |
Component |
True |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
1 |
Neisseria meningitidis serogroup C conjugated antigen |
Is a |
True |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
|
Neisseria meningitidis serogroup C capsular polysaccharide antigen |
Is a |
True |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
|
Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
2 |
Vaccine product containing only Neisseria meningitidis serogroup C antigen (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
1 |
Neisseria meningitidis serogroup A and C only vaccine product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
1 |
Vaccine product containing only Neisseria meningitidis serogroup A, C, W135 and Y antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
3 |
Vaccine product containing only Haemophilus influenzae type b and Neisseria meningitidis serogroup C and Y antigens (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Neisseria meningitidis serogroup C antigen |
Inferred relationship |
Some |
3 |